A recent study published in The British Medical Journal finds link to increased risk of hospitalization in the elderly
Orange County, CA - September 30th 2016 - The British Medical Journal recently published a study concluding that painkillers are linked to an increased risk of heart failure. Similar to opioids, a correlation has been found in non-steroidal anti-inflammatory drugs, (NSAIDs) used to treat pain and inflammation, and ailments in elderly patients. While knowledge of the risks for heart failure when taking NSAIDs is not new, this study further divulges cautionary information.
Researchers from the University of Milano-Bicocca, in Italy, used data from 10 million people on NSAIDs treatment plans and a control group of non-users. Individuals from countries around the world, such as the UK, Netherlands, Italy, and Germany, averaging at about 77 years of age were used in the study. Researchers, upon analyzing the two groups’ vitals, found 92,000 patients in the using group required hospital admittance due to heart failure.
The dossier showed that taking any NSAID just within the 2 weeks prior to the study, made patients 19 percent more likely to undergo hospitalization due to heart complications than those who used similar treatment plans in the past.
Compiled figures revealed that consumption of the traditional NSAIDs, diclofenac, indomethacin, ibuprofen, ketorolac, nimesulide, naproxen and piroxicam , or COX 2 inhibitors etoricoxib and rofecoxib further increased a patient’s risk of admission. Two particularly high risk medications used, naproxen and ketorolac, ranged anywhere from 16 to 83 percent increase in prospect. Study researcher Giovanni Corrao stated that, although plausible, risk of hospital admission depends on the medication and dose ingested and is not guaranteed upon consumption.
While people of all ages take NSAIDs, this study focused on elderly patients, who are, generally speaking, in poorer health than younger individuals. Health experts believe that the study results are a cause for concern among the elderly, but not for those under the age of 65.
Professor Peter Weissberg, medical director at The British Heart Foundation (BHF) has said patients, “should only take the lowest effective dose for the shortest possible time.”
While the results don’t purport much information for younger patients, Helen Williams, consultant pharmacist for cardiovascular disease at the Royal Pharmaceutical Society, articulates that young people who take the drug recurrently should be under supervision of an attending physician in case of other complications, such as kidney deterioration.
She goes on to mention the importance of taking medication correctly, citing ibuprofen, an anti-inflammatory, as a commonly misused drug.
“If you've got a headache, it's unlikely that there's going to be [an issue with] inflammation and paracetamol is fine."
Contact Ampronix:
Email: info@ampronix.com
International Sales: +1 949-273-8000
Domestic Sales: 1800-400-7972 for US and Canada
Follow Us:
Share This Article:
View our Product Catalog Online Here
About Ampronix
Ampronix is a renowned authorized master distributor of the medical industry's top brands as well as a world-class manufacturer of innovative technology. Since 1982, Ampronix has been dedicated to meeting the growing needs of the medical community with its extensive product knowledge, outstanding service, and state-of-the-art repair facility. Ampronix prides itself on its ability to offer tailored, one-stop solutions at a faster and more cost-effective rate than other manufacturers. Ampronix is an ISO & ANSI/ESD certified facility. To learn more go here.
A recent study published in The British Medical Journal finds link to increased risk of hospitalization in the elderly Orange County, CA – September 30th 2016 – The British Medical Journal recently published a study concluding that painkillers are linked to an increased risk of heart failure. Similar to opioids, a correlation has been found in […]